首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1902342

整形外科生物製剂市场规模、份额及成长分析（按产品类型、应用、最终用户和地区划分）－2026-2033年产业预测

Orthobiologics Market Size, Share, and Growth Analysis, By Product Type (Demineralized Bone Matrix (DBM), Allograft), By Type (Knee, Ankle), By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球整形外科生物製剂市场规模将达到 64.3 亿美元，到 2025 年将达到 67.8 亿美元，到 2033 年将达到 104.1 亿美元，预测期（2026-2033 年）的复合年增长率为 5.5%。

全球整形外科生物製剂市场涵盖多种旨在促进肌肉骨骼疾病和损伤癒合的产品，包括干细胞、骨移植和富血小板血浆（PRP）疗法。再生医学的进步、人口老化以及整形外科手术量的增加是推动市场成长的主要因素。然而，严格的监管核准、缺乏标准化以及不断上涨的治疗成本等挑战可能会阻碍市场发展。儘管存在这些障碍，但整形外科生物製剂应用范围的扩大、研究活动的增加以及对个人化医疗日益增长的关注等机会，预计将推动市场显着增长。这种成长潜力凸显了创新和可近性在解决肌肉骨骼健康问题的重要性。

推动全球整形外科生物製剂市场发展的因素

全球整形外科生物製剂市场的成长主要得益于技术进步和持续的研发活动。富血小板血浆（PRP）和干细胞疗法等治疗方法创新，以及各种相关技术，正在提高整形外科生物製剂的可及性、可用性和有效性。这些进展不仅促进了新治疗方案和产品的推出，还有助于改善癒合过程和整体復健效果。因此，这些现代化方法和治疗方法的不断发展正对市场产生积极影响。

全球整形外科生物製剂市场限制因素

全球整形外科生物製剂市场的发展受到许多因素的限制，包括需要进行大量研究以及各种治疗方法疗效差异较大。儘管该领域存在进步和创新的潜力，但检验特定整形外科生物製剂疗效的临床研究深度不足，可能会限制医疗机构对其的接受度。此外，不同研究报告的结果不一致，可能导致人们对某些产品的疗效产生怀疑，最终影响其在临床实务中的应用。缺乏确凿的证据阻碍了整形外科生物製剂的广泛应用和公众信任，而骨科生物製剂对于再生医学治疗至关重要。

全球整形外科生物製剂市场趋势

全球整形外科生物製剂市场呈现强劲成长趋势，这主要得益于富血小板血浆（PRP）疗法在治疗各种肌肉骨骼疾病（包括关节疼痛、软组织损伤和术后復健）方面的应用日益广泛。随着医疗专业人员认识到PRP疗法在加速癒合过程中的潜在益处，这种再生医学方法正变得越来越普及。此外，PRP製备和给药通讯协定的标准化工作也在不断推进，这提高了治疗方法的可靠性，从而增强了治疗的可重复性和疗效。因此，整形外科生物製剂产业有望迎来显着成长，并受益于能够改善治疗效果和提升患者满意度的各项技术进步。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Stryker Corporation（USA）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（USA）
DePuy Synthes（Johnson & Johnson）（USA）
Bioventus LLC（USA）
Arthrex, Inc.（USA）
NuVasive, Inc.（USA）
Orthofix International NV（Netherlands）
Globus Medical, Inc.（USA）
Kuros Biosciences AG（Switzerland）
Xtant Medical Holdings, Inc.（USA）
Harvest Technologies Corporation（USA）
Wright Medical Group NV（Netherlands）
Smith & Nephew plc（UK）
Bone Biologics Corp.（USA）
Sano Orthopedics（USA）

结论与建议

简介目录

Product Code: SQMIG35D2070

Global Orthobiologics Market size was valued at USD 6.43 Billion in 2024 and is poised to grow from USD 6.78 Billion in 2025 to USD 10.41 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global orthobiologics market encompasses a diverse array of products designed to enhance the healing of musculoskeletal conditions and injuries, including stem cells, bone grafts, and PRP (platelet-rich plasma) therapies. Market growth is driven by advancements in regenerative medicine, an aging population, and an increase in orthopedic procedures. However, challenges such as stringent regulatory approvals, a lack of standardization, and high treatment costs may hinder progress. Despite these obstacles, the market is poised for significant expansion, supported by opportunities arising from broader applications of orthobiologics, increased research initiatives, and a growing focus on personalized medicine. This potential for growth underscores the importance of innovation and accessibility in addressing musculoskeletal health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segments Analysis

Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region. Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy. Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others. Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Orthobiologics Market

The growth of the global orthobiologics market is significantly driven by advancements in technology and ongoing research and development efforts. Innovations in therapies such as platelet-rich plasma (PRP) and stem cell treatments, along with various related techniques, are enhancing the accessibility, availability, and effectiveness of orthobiologics. These developments are not only facilitating the introduction of new treatment options and products but also contributing to improved healing processes and overall recovery outcomes. As a result, the market is experiencing a positive impact from these modernized approaches and the continuous evolution of therapeutic modalities.

Restraints in the Global Orthobiologics Market

The Global Orthobiologics market is significantly hindered by the demand for extensive research and the variability of outcomes associated with various therapies. Although advancements and innovations hold potential, the insufficient depth of clinical research that validates the efficacy of certain orthobiologics can limit their acceptance among healthcare providers. Additionally, inconsistent findings across studies may foster skepticism regarding the effectiveness of specific products, ultimately impacting their adoption in clinical practice. This lack of conclusive evidence creates a barrier, preventing widespread utilization and confidence in orthobiologics, which are vital for treatment in regenerative medicine.

Market Trends of the Global Orthobiologics Market

The Global Orthobiologics market is witnessing a robust upward trend, driven by the increasing adoption of Platelet-Rich Plasma (PRP) treatments for various musculoskeletal conditions, including joint pain, soft tissue injuries, and post-surgical recovery. This regenerative approach is becoming more prevalent as healthcare professionals recognize its potential benefits in enhancing healing processes. Additionally, ongoing efforts to standardize PRP preparation and administration protocols are fostering greater confidence in these therapies, thereby improving their reproducibility and efficacy. As a result, the orthobiologics sector is positioning itself for significant growth, capitalizing on advancements that enhance treatment outcomes and patient satisfaction.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Orthobiologics Market Size by Product Type & CAGR (2026-2033)

Market Overview
Demineralized Bone Matrix (DBM)
Allograft
Bone morphogenetic protein (BMP)
Viscosupplementation
Synthetic bone substitutes
Stem cell therapy

Global Orthobiologics Market Size by Type & CAGR (2026-2033)

Market Overview
Knee
Ankle
Hip
Wrist & Shoulder
Spine
Others

Global Orthobiologics Market Size by Application & CAGR (2026-2033)

Market Overview
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial & Dental Applications

Global Orthobiologics Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals & Ambulatory Centers
Research & Academic Institute
Dental Clinics

Global Orthobiologics Market Size & CAGR (2026-2033)

North America (Product Type, Type, Application, End-user)
- US
- Canada
Europe (Product Type, Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes (Johnson & Johnson) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix International N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Globus Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuros Biosciences AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xtant Medical Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Harvest Technologies Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bone Biologics Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sano Orthopedics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments